机器学习改善系统性红斑狼疮10年动脉粥样硬化斑块进展与心血管事件预测
该前瞻性10年随访研究纳入111例无既往心血管事件的系统性红斑狼疮(SLE)患者,评估11种心血管疾病(CVD)风险评分预测斑块进展和CVD事件的表现,并开发机器学习模型。结果显示所有评分性能欠佳,机器学习模型整合QRISK3与疾病相关及传统风险因素后,性能显著优于所有评估评分。
要点
- 传统和SLE适配评分均低估SLE患者10年CVD事件和斑块进展风险。
- QRISK3是唯一与CVD事件和/或斑块进展独立相关的工具(HR 1.87,p=0.027)。
- 机器学习模型整合QRISK3与疾病及传统风险因素,性能显著优于所有评分。
核心结论
- 传统和SLE适配工具低估SLE患者CVD事件和动脉粥样硬化进展风险。
- 机器学习模型将疾病特异性和传统心血管风险因素纳入QRISK3,改善CVD风险分层。
研究设计与样本
- 前瞻性10年随访颈动脉和股动脉超声研究,纳入111例无既往CVD事件的SLE患者。
- 评估11种CVD风险评分(7种传统、4种SLE适配)预测斑块进展和CVD事件的表现。
- 开发并内部验证基于机器学习的梯度提升模型。
主要发现
- 中位年龄43.0岁,91%女性;53例(47.7%)出现新斑块,8例(7.2%)发生CVD事件。
- 所有评分性能欠佳:敏感性0.00-0.44,AUC 0.58-0.79,Brier Score 0.44-0.71。
- 多变量分析中QRISK3是唯一与CVD事件和/或斑块进展独立相关的工具(HR 1.87,p=0.027)。
- 机器学习评分整合QRISK3、疾病相关因素(病程、累积糖皮质激素剂量、DORIS达标、抗磷脂抗体、羟氯喹)及额外传统CVD风险因素(体力活动、腰围),性能显著优于所有评估评分。
关键数值与推荐
- 11种CVD风险评分中7种传统、4种SLE适配。
- QRISK3与CVD事件和/或斑块进展独立相关(HR 1.87,p=0.027)。
临床怎么用
- SLE患者心血管风险分层应考虑使用整合疾病相关和传统风险因素的机器学习模型。
- QRISK3可作为SLE患者CVD风险预测的基础工具之一。
局限性
- 样本量较小(111例),CVD事件数少(8例)。
- 机器学习模型仅进行内部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the performance of generic and disease-adapted tools in predicting 10-year cardiovascular disease (CVD) events and atherosclerotic plaque progression risk in systemic lupus erythematosus (SLE), and develop a machine learning-based model to improve cardiovascular risk stratification. METHODS: In a prospective 10-year follow-up carotid and femoral ultrasound study of patients with SLE without prior CVD events, we assessed the performance of 11 CVD risk scores (7 conventional, 4 SLE-adapted) to predict atherosclerotic plaque progression and incident CVD events. We used discrimination (sensitivity, specificity, area under the curve [AUC], Youden index), calibration (Brier Score [BS]) and classification (Matthews correlation coefficient, F1 score) metrics, and logistic regression and time-to-event analyses. A machine learning-based gradient boosting model was developed and internally validated. RESULTS: Among 111 patients (91% female, median age: 43.0 years) with 10-year ultrasonography follow-up, 53 (47.7%) developed new plaques, and 8 (7.2%) had incident CVD events. All scores demonstrated suboptimal performance; sensitivity: 0.00-0.44, AUC 0.58-0.79, and BS: 0.44-0.71. In multivariable analysis, QRISK3 was the only tool independently associated with CVD events and/or plaque progression (HR:1.87, p = 0.027). A machine learning-based score that integrates QRISK3 with disease-related risk factors (disease duration, cumulative glucocorticoid dose, DORIS achievement, antiphospholipid antibodies, hydroxychloroquine) and additional traditional CVD risk factors (physical activity, waist circumference), demonstrated significantly better performance compared to all evaluated scores. CONCLUSION: Conventional and SLE-adapted tools underestimate CVD events and atherosclerosis progression risk in SLE. A machine learning-based model incorporating disease-specific and traditional cardiovascular risk factors into QRISK3 improves CVD risk stratification.
引用
- Papazoglou N, Sfikakis PP, Tektonidou MG, et al. Machine learning improves 10-year prediction of atherosclerotic plaque progression and cardiovascular events in systemic lupus erythematosus. Rheumatology (Oxford). 2026. PMID: 42954301. doi:10.1093/rheumatology/keag607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。